Chronic Migraine Study
This clinical trial investigates a preventive therapy for chronic migraines, a condition defined by 15 or more headache days per month. The study examines whether the treatment can reduce the frequency and severity of migraines over a sustained period, improving daily functionality.
ELIGIBILITY CRITERIA
We are looking for participants who meet the following criteria:
- Diagnosed with chronic migraines for at least six months.
- Failed at least two preventive treatments in the past.
Study Details
Participants will receive an injectable medication targeting CGRP, a molecule linked to migraines. The study involves tracking headache frequency through a migraine diary, regular check-ups, and neurological assessments. It will also evaluate secondary outcomes like improved productivity, reduced medication use, and enhanced sleep quality.
Compensation is provided as part of this paid clinical trial, offering participants a chance to earn money while helping to advance migraine research.
Do you meet the criteria and want to join the study?
If your child meets the criteria and you are interested in contributing to this important research, they may qualify for this study. For more information or to discuss eligibility, please contact the Haltha team at Haltha Connect.
Take part in live studyUnlock Exclusive Content by Subscribing to Our Updates
Stay informed about the latest advancements, breakthroughs, and trends in medical research
